市場調查報告書
商品編碼
1159230
消化管支架的全球市場:預測(2022年~2028年)Gastrointestinal Stent Market 2022-2028 |
全球消化管支架的市場規模在預測期間內預計將以約5.5%的年複合成長率擴大。
本報告提供全球消化管支架市場相關調查,提供市場概要,以及各產品類型,各技術類型,各材料,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。
Global Gastrointestinal stent Market Size, Share & Trends Analysis Report by Product Type (Biliary Stent, Duodenal Stent, Colonic Stent, Pancreatic Stent, Esophageal Stent), By Technology Type (Anti Migratory Stent, Drug Eluting Stent, Radioactive Stent, Anti Reflux Stent, Shape Modified Stent), By Material (Plastic Stent, Self-Expanding Metal Stent( Stainless Steel Stent, Nitinol Stent), Covered Self Expandable Metallic Stent, Biodegradable or Drug Eluting Stent) And By End User (Hospital, Specialty Clinic and Ambulatory Surgical Center) Forecast 2022-2028
The global gastrointestinal stent market is anticipated to grow at a CAGR of around 5.5% during the forecast period. The Gastrointestinal stent is designed for therapies in various body ailments which are causing a blockage or obstruction in the gastrointestinal tract. GI stents are used in many conditions in the human body. Some of them are GI tract tumor palliation, GI bleeding, in leak sealing in the GI tract. In the placement of stents in the human body, there are two conditions that need to be fulfilled. First is technical success which means the successful placement of a stent in the position. The second is clinical success which means a point or timeframe after which relief from the condition is seen. It may be 3-30 days after placement, 3 months, or even beyond. GI stenting is used in many cases of GI cancer or IBD-related issues as it has a high proportion of success than other therapy used. For instance, in Aug 2020, in a meeting of the Society of American Gastrointestinal and endoscopic surgeon, Jorge A. arroyo who is an MD in medicine said that using a stent in closing a type of perforated duodenal ulcer was found feasible and did not differ with surgical closure. This study was published in SAGES Journal.
The global gastrointestinal stent market is segmented based on product type, technology type, material, and end user. Based on product type, the market is segmented into biliary stent, duodenal stent, colonic stent, pancreatic stent, esophageal stent. Based on the technology type, the market is sub-segmented into anti migratory stent, drug eluting stent, radioactive stent, anti-reflux stent, shape modified stent. Based on material the market is sub-segmented into plastic stent, self-expanding metal stent, covered self-expandable metallic stent, biodegradable or drug eluting stent. Based on end-users the market is sub-segmented into hospital, specialty clinic, and ambulatory surgical center. Among these, the self-expanding metal segment is anticipated to grow at a widespread rate during the forecast period. These stents are useful as the complication rate, the hospitalization rate was less after placement of stent as compared to another kind of stents. They will gain more changes in their design in the future. They are used in many GI tract problems. For instance, in July 2020, Olympus Corporation announced the launch of HANAROSTENT Esophagus TTS, which is a self-expanding metal stent. This will be helpful in treating the trachea esophageal fistula. This easily fits in a gastroscope and is accordingly placed in the esophagus.
Geographically market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is going to be a good market for gastrointestinal stents. Colorectal cancer stands in second place for increasing deaths caused by cancer in Americans. For instance, in Feb 2021, around 51,000 Americans die due to colorectal cancer annually. This data is by GI alliance which is America's largest independent gastroenterology services organization.
The major companies serving the global Gastrointestinal stent market include Becton, Dickinson and Company, Boston Scientific Corp., Cantel Medical Corp., Conmed Corp., Cook Group Inc., and others. Research and developments in GI therapy are opening doors for market players for a more innovative and safer medical device. For instance, in April 2021, Exosome coated stent was developed by researchers from North Carolina State University which has a smart release trigger. This will help provide regenerative stem cell therapy to tissues that are damaged or which need blood. They help in tissue repair.
Research Methodology
The market study of the global gastrointestinal stent market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers:
4.4 Global Gastrointestinal Stent Market by end user